INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Aug 30, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,479 |
Aug 29, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 1,500 | $144.92 | 74,505 |
Aug 29, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 9,386 | $145.44 | 65,119 |
Aug 29, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 5,998 | $146.41 | 59,121 |
Aug 28, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | $21.92 | 99,121 |
Aug 28, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 6,017 | $145.70 | 93,104 |
Aug 28, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 17,099 | $145.70 | 76,005 |
Aug 28, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | -- | 55,438 |
Aug 28, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,017 | -- | 6,017 |
Jun 20, 2012 |
SVP Res & Dev Sciences
|
SVP Res & Dev Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,479 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.